Comprehensive genomic and immune profiling for the detection of clinically significant tumor biomarkers

Analytical validation of OmniSeq® INSIGHT whole transcriptome sequencing assay to facilitate precision oncology through tumoronly testing in solid tumors

Analytical validation of OmniSeq® INSIGHT whole exome sequencing assay to facilitate precision oncology through tumor only testing in solid tumors

Validation of automated nucleic acid extraction using Covaris® Gen3 extraction methodology on the Assay-Ready Workstation

Enabling Access to Genomic Profiling through Decentralized Liquid Biopsy Solution PGDx elioTM plasma focus Dx

Hereditary cancer testing: Empowering patients through genetic insights

Hereditary cancer testing: Empowering patients through genetic insights

Labcorp Acquires Select Assets of Lab Works

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, has finalized its acquisition of select assets and molecular testing location of Lab Works, an accredited independent clinical laboratory located in Birmingham, Alabama. 

Molecular Tumor Board: 58-year-old male with breast carcinoma and BRCA2 R3128* mutation

Though less common than in women, understanding male breast cancer and symptoms can lead to earlier detection and improved outcomes.